PAPER Shimamura MI, Satoh K

Challenges and Revisions in Diagnostic Criteria: Advancing Early Detection of Prion Diseases.

Int J Mol Sci. 2025 Feb 26;26(5) PubMed.

PAPER Li Z, Guo H, Ge Y, Li X, Dong F, Zhang F

Decoding Alzheimer's Disease With Depression: Molecular Insights and Therapeutic Target.

J Cell Mol Med. 2025 Mar;29(5):e70454. PubMed.

PAPER Kakino Y, Hattori Y, Ogata S, Nakaoku Y, Nishimura K, Iida H, Ihara M

Cerebral Hemodynamic Impairment and Cognitive Dysfunction in APOE4 Carriers With Asymptomatic Carotid Artery Stenosis/Occlusion.

J Am Heart Assoc. 2025 Mar 13;:e039210. Epub 2025 Mar 13 PubMed.

PAPER Kim C, Hovakimyan A, Zagorski K, Antonyan T, Petrushina I, Davtyan H, Chailyan G, Hasselmann J, Iba M, Adame A, Rockenstein E, Szabo M, Blurton-Jones M, Cribbs DH, Ghochikyan A, Masliah E, Agadjanyan MG

Retraction Note: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies.

NPJ Vaccines. 2025 Mar 12;10(1):47. PubMed. Retracted paper.

PAPER Forrest SL, Sadia N, Khodadadi M, Tator C, Green R, Tartaglia MC, Kovacs GG

Unprecedented Combination of Rare Degenerative Pathologies in an Octogenarian Ex-Football Player.

Neuropathology. 2025 Mar 13; Epub 2025 Mar 13 PubMed.

PAPER Songhori N, Goushky MS, Khaleghi MM, Mojerloo M, Sadeghi M, Mozafar M, Aghdam ZB, Ghajar M, Kianifar Y, Karimzadeh F, Khosravi F, Mayeli M

Growth-Associated Protein 43 Levels in the Cerebrospinal Fluid Correspond to the Cerebral Blood Flow Alterations in Alzheimer's Dementia Continuum: An Original Study.

Health Sci Rep. 2025 Mar;8(3):e70534. Epub 2025 Mar 11 PubMed.

PAPER Li X, Pei R, Fei Z, Chen Z, Lin F, Sun P, Cao H

Could Blood Transfusion Increase the Risk of Alzheimer's Disease? A Narrative Review.

Healthcare (Basel). 2025 Feb 20;13(5) PubMed.

PAPER Fułek M, Hachiya N, Gachowska M, Beszłej JA, Bartoszewska E, Kurpas D, Kurpiński T, Adamska H, Poręba R, Urban S, Fułek K, Leszek J

Cellular Prion Protein and Amyloid-β Oligomers in Alzheimer's Disease-Are There Connections?

Int J Mol Sci. 2025 Feb 27;26(5) PubMed.

PAPER Tang H, Li L, Yu Q, Chen L, Xu X, Meng Z, Zeng Y, Chen F, Muzaffar H, Wang W, Zhao X, Liang G

Sclareol improves the pathology of Alzheimer's disease by inhibiting microglial inflammation via interacting with CDK9.

Phytomedicine. 2025 Apr;139:156504. Epub 2025 Feb 13 PubMed.

Aurore Delvenne on With Age, Macrophages Chew up the Blood-CSF Barrier

COMMENT The mechanisms underlying the disruption of the choroid plexus in aging and age-related neurodegenerative diseases remain relatively underexplored. In this insightful study, Chen et al. provide compelling evidence that macrophage activity plays a crucial

Tord Labuda

Alzinova AB
, Sweden

Stefan Pierrou

Alzinova AB
, Sweden

PAPER Alldred MJ, Ibrahim KW, Pidikiti H, Lee SH, Heguy A, Chiosis G, Mufson EJ, Stutzmann GE, Ginsberg SD

Profiling hippocampal neuronal populations reveals unique gene expression mosaics reflective of connectivity-based degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Front Mol Neurosci. 2025;18:1546375. Epub 2025 Feb 26 PubMed.

PAPER Sohur US, Gray DL, Duvvuri S, Zhang Y, Thayer K, Feng G

Phase 1 Parkinson's Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well Tolerated.

Neurol Ther. 2018 Dec;7(2):307-319. Epub 2018 Oct 25 PubMed.

PAPER Gray DL, Allen JA, Mente S, O'Connor RE, DeMarco GJ, Efremov I, Tierney P, Volfson D, Davoren J, Guilmette E, Salafia M, Kozak R, Ehlers MD

Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor.

Nat Commun. 2018 Feb 14;9(1):674. PubMed.